HC Wainwright & Co. initiated coverage on Assembly Biosciences with a new price target
$ASMB
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. initiated coverage of Assembly Biosciences with a rating of Neutral and set a new price target of $3.50